Anaesthetic Management of a Patient With LDB3-Associated Myopathy Undergoing Prostate Biopsy Under Total Intravenous Anaesthesia: A Case Report

Read full text
Authors: Shashikant Shankar Swami, Mark Campbell, Deepika Rani Basappakokati
Cited by: 0
References: 14

Abstract

Mutations in the LDB3 gene are implicated in myofibrillar myopathy and cardiomyopathy. Consider cardiac conduction defects and the muscle's sensitivity to some anaesthetics when providing anaesthesia in the perioperative period. We present the anaesthetic management of a 76-year-old man with genetically confirmed LDB3 mutation who presented for prostate biopsy with a background of progressive distal myopathy, mild cardiac involvement, and normal activities of daily living (ADL), undergoing anaesthesia using total intravenous anaesthesia (TIVA) to avoid the use of volatile agents or neuromuscular blockers. In this patient with a history of LDB3-associated myopathy, the use of TIVA provided a safe and effective technique of anaesthesia, and reinforced the need for an individualised anaesthetic strategy in neuromuscular disease (NMD).

Fields of Study & Subjects

Anesthesia and Sedative Agents Anesthesia and Pain Management Cardiac Anesthesia and Surgical Outcomes

Publication details

Journal / source
Cureus
Volume
18
Issue
2
Pages
e102869–e102869
Publication date
3 February 2026
Language
EN